STOCK TITAN

Home Run! Adia Med of Winter Park's AHCA Triumph Brings Insurance-Covered Healing to Patients

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Adia Nutrition (OTCQB: ADIA) has achieved a significant milestone as its Adia Med of Winter Park clinic receives Agency for Health Care Administration (AHCA) approval, enabling insurance coverage acceptance for its treatments. The clinic, which opened in January 2025, specializes in innovative therapies including Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Multiple Sclerosis and therapeutic plasma exchange (TPE). This approval positions Adia Med to enter the $4.9 trillion healthcare insurance market and makes their cutting-edge regenerative treatments more accessible to patients across Florida. The clinic will now work directly with patients to advocate for insurance coverage of their treatments, potentially reducing financial barriers to advanced medical care.
Adia Nutrition (OTCQB: ADIA) ha raggiunto un importante traguardo: la sua clinica Adia Med di Winter Park ha ottenuto l'approvazione dall'Agency for Health Care Administration (AHCA), permettendo l'accettazione delle coperture assicurative per i suoi trattamenti. La clinica, inaugurata nel gennaio 2025, è specializzata in terapie innovative come il Trapianto Autologo di Cellule Staminali Ematopoietiche (aHSCT) per la Sclerosi Multipla e lo scambio terapeutico di plasma (TPE). Questa approvazione consente ad Adia Med di entrare nel mercato assicurativo sanitario da 4,9 trilioni di dollari, rendendo i loro trattamenti rigenerativi all'avanguardia più accessibili ai pazienti della Florida. La clinica collaborerà direttamente con i pazienti per promuovere la copertura assicurativa dei trattamenti, riducendo potenzialmente le barriere economiche per cure mediche avanzate.
Adia Nutrition (OTCQB: ADIA) ha alcanzado un hito importante: su clínica Adia Med en Winter Park ha recibido la aprobación de la Agencia para la Administración del Cuidado de la Salud (AHCA), lo que permite la aceptación de coberturas de seguros para sus tratamientos. La clínica, inaugurada en enero de 2025, se especializa en terapias innovadoras como el Trasplante Autólogo de Células Madre Hematopoyéticas (aHSCT) para Esclerosis Múltiple y el intercambio terapéutico de plasma (TPE). Esta aprobación posiciona a Adia Med para ingresar al mercado de seguros de salud de 4,9 billones de dólares, haciendo que sus tratamientos regenerativos de vanguardia sean más accesibles para los pacientes en Florida. La clínica trabajará directamente con los pacientes para defender la cobertura de seguros para sus tratamientos, lo que podría reducir las barreras financieras para la atención médica avanzada.
Adia Nutrition(OTCQB: ADIA)는 중요한 이정표를 달성했습니다. Winter Park에 위치한 Adia Med 클리닉이 건강 관리 행정국(AHCA)의 승인을 받아 치료에 대한 보험 적용이 가능해졌습니다. 2025년 1월에 개원한 이 클리닉은 다발성 경화증 치료를 위한 자가 조혈모세포 이식(aHSCT)과 치료용 혈장 교환(TPE) 등 혁신적인 치료법을 전문으로 합니다. 이번 승인을 통해 Adia Med는 4.9조 달러 규모의 의료 보험 시장에 진입할 수 있게 되었으며, 플로리다 전역의 환자들이 최첨단 재생 치료를 더 쉽게 이용할 수 있게 되었습니다. 클리닉은 이제 환자들과 직접 협력하여 치료에 대한 보험 적용을 지원함으로써 첨단 의료 서비스에 대한 경제적 장벽을 낮출 수 있을 것입니다.
Adia Nutrition (OTCQB : ADIA) a franchi une étape importante : sa clinique Adia Med de Winter Park a obtenu l'approbation de l'Agency for Health Care Administration (AHCA), permettant ainsi l'acceptation de la couverture d'assurance pour ses traitements. La clinique, ouverte en janvier 2025, est spécialisée dans des thérapies innovantes telles que la transplantation autologue de cellules souches hématopoïétiques (aHSCT) pour la sclérose en plaques et l'échange thérapeutique de plasma (TPE). Cette approbation positionne Adia Med pour entrer sur le marché de l'assurance santé de 4,9 trillions de dollars et rend leurs traitements régénératifs de pointe plus accessibles aux patients de Floride. La clinique travaillera désormais directement avec les patients pour défendre la prise en charge de leurs traitements par les assurances, réduisant ainsi potentiellement les barrières financières à des soins médicaux avancés.
Adia Nutrition (OTCQB: ADIA) hat einen bedeutenden Meilenstein erreicht: Die Adia Med Klinik in Winter Park erhielt die Genehmigung der Agency for Health Care Administration (AHCA), wodurch die Akzeptanz von Versicherungsleistungen für ihre Behandlungen ermöglicht wird. Die im Januar 2025 eröffnete Klinik spezialisiert sich auf innovative Therapien wie die autologe hämatopoetische Stammzelltransplantation (aHSCT) bei Multipler Sklerose und therapeutischen Plasmapherese (TPE). Diese Genehmigung versetzt Adia Med in die Lage, in den 4,9 Billionen Dollar schweren Gesundheitsversicherungsmarkt einzutreten und macht ihre fortschrittlichen regenerativen Behandlungen für Patienten in ganz Florida zugänglicher. Die Klinik wird nun direkt mit Patienten zusammenarbeiten, um die Versicherungsdeckung für ihre Behandlungen zu fördern und somit finanzielle Hürden für fortschrittliche medizinische Versorgung zu verringern.
Positive
  • AHCA approval enables insurance coverage acceptance, expanding patient accessibility
  • Entry into the $4.9 trillion healthcare insurance market represents significant business opportunity
  • Ability to provide insurance-covered innovative treatments like aHSCT and TPE
  • Clinic compliance with Florida's healthcare standards validates operational quality
Negative
  • None.

Winter Park, Florida--(Newsfile Corp. - June 16, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a leading innovator in regenerative medicine and nutritional supplements, is thrilled to announce that its state-of-the-art clinic, Adia Med of Winter Park, has received full approval from the Agency for Health Care Administration (AHCA). This milestone allows Adia Med of Winter Park to accept insurance, marking a significant advancement in providing accessible, life-changing treatments to patients across Florida.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/10520/255556_ahca_certificate_550.jpg

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/255556_ahca_certificate.jpg

The AHCA approval positions Adia Med of Winter Park as a premier destination for innovative therapies, including Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Multiple Sclerosis (MS) and other autoimmune conditions, as well as therapeutic plasma exchange (TPE), and other breakthrough medical treatments. By accepting insurance, Adia Nutrition can now work directly with patients to advocate for coverage, making transformative treatments more affordable and accessible.

"This AHCA approval is a game-changer for Adia Nutrition and our patients," said Larry Powalisz, Chief Executive Officer of Adia Nutrition. "Being able to accept insurance means we can partner with patients to fight for their right to coverage for innovative therapies like aHSCT, which have the potential to dramatically improve quality of life. We're committed to breaking down financial barriers and delivering world-class care."

Located in Winter Park, Florida, Adia Med of Winter Park, which opened in January 2025, is equipped to deliver cutting-edge regenerative treatments tailored to individual patient needs. The clinic's approval by AHCA underscores its compliance with Florida's rigorous healthcare standards, reinforcing Adia Nutrition's entry in the $4.9 trillion health-care insurance market. Historical | CMS

Patients interested in exploring insurance-covered treatment options at Adia Med of Winter Park are encouraged to fill out the contact form at www.adiamed.com.

For questions, inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.

About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.

Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition

Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255556

FAQ

What does the AHCA approval mean for Adia Nutrition (ADIA) patients?

The AHCA approval allows Adia Med of Winter Park to accept insurance coverage, making their innovative treatments more affordable and accessible to patients. The clinic can now advocate directly for patient coverage of treatments.

What treatments does Adia Med of Winter Park offer under insurance coverage?

The clinic offers innovative therapies including Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Multiple Sclerosis, therapeutic plasma exchange (TPE), and other regenerative treatments.

When did Adia Med of Winter Park open and where is it located?

Adia Med of Winter Park opened in January 2025 and is located in Winter Park, Florida.

How large is the healthcare insurance market that ADIA is entering?

According to the press release, ADIA is entering a $4.9 trillion healthcare insurance market.

How can patients access treatment at Adia Med of Winter Park?

Interested patients can fill out a contact form at www.adiamed.com to explore insurance-covered treatment options.
Adia Nutrition

OTC:ADIA

ADIA Rankings

ADIA Latest News

ADIA Stock Data

8.63M
Shell Companies
Financial Services
Link
United States
Kurtistown